![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Deal date
KANDO id: 713462
Financial Transaction:
Series D
Calypso Medical Technologies Inc
Currency
United States Dollar
Value in original currency
42,200,000
Value in USD
42,200,000
Lead investor
| Investor | Country | Notes | |
|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Apothecary Capital |
||
|
|
Glenview Capital Management |
||
|
Pequot Capital Management Inc |
United States |
Round participants
| Investor | Country | Notes | |
|---|---|---|---|
|
Frazier Healthcare VenturesInvestment firm providing growth and venture capital to healthcare companies. |
United States | |
|
Integra Ventures |
United States | |
|
Kaiser Permanente Ventures(KP Ventures)The corporate venture capital arm of Kaiser Permanente |
United States | |
|
|
Merlin Biomed |
||
|
RiverVest Venture Partners(RiverVest Ventures) |
United States | |
|
Versant Ventures Management LLCVenture capital firm focused on making investments in the healthcare and biotechnology industries. |
United States |